Suffering from several chronic uncontrollable bacterial infections often leads to terminal diseases, at least in immune-compromised/aged individuals, if the innards become infected. On analysis, it is found that drug-resistant bacteria are the causative organism of morbidity and mortality.1 Indeed, pathogenic bacteria gain multidrug resistant (MDR) traits due to their simple genomes, and concomitantly natural consortia of bacteria help mediate their evolutionary exchanges of genetic materials.2 As antibiotics are microbial in origin, targeted microbes develop resistance to the applied antibiotics intrinsically; the mutation frequency of antibiotic-resistance is recorded as one in 106 – 108 cells.3 However, small and clean a hospital be it may, the chance of spreading pathogenic bacteria to health personnel, who often serve as reservoirs along with hospitalized patients, should be ample aside from the spread from fomites and devices.4 Furthermore, nosocomial infections of patients with burn and surgical injuries, as well as life-threatening urinary tract infections or even enteropathogenic episodes, frequently lead to bacteraemia/septicaemia.5 and 6 Any infection in a patient must be controlled forthwith, and the surveillance of a group of pathogens can be undertaken at a hospital for the estimation required for assurance on prescribed antibiotics. The evolutionary capabilities of a few pathogenic Gram-negative (GN) bacteria are so versatile that notorious pandrug resistant (PDR; some strains of these bacteria are resistant to almost all contemporary antibiotics) strains have emerged; they are identified mainly as Escherichia coli, Enterobacter aerogenes and Klebsiella pneumoniae. 7 and 8 The outbreak of accredited MDR bacterial strains and their rapid spread affects the cost of hospitalization and the public health sector, leading to the urgency behind the implementation of some avant-garde drugs as antimicrobials.